These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15184946)

  • 21. Outcome of intravitreal triamcinolone in uveitis.
    Kok H; Lau C; Maycock N; McCluskey P; Lightman S
    Ophthalmology; 2005 Nov; 112(11):1916.e1-7. PubMed ID: 16171868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The response pattern of intravitreal triamcinolone injection for non-AMD macular edema.
    Bhurayanontachai P; Ratanasukon M; Ma-a-lee A
    J Med Assoc Thai; 2009 Jan; 92(1):58-63. PubMed ID: 19260245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion.
    Hayashi K; Hayashi H
    Am J Ophthalmol; 2005 Jun; 139(6):972-82. PubMed ID: 15953425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ocular effects of intravitreal triamcinolone acetonide in dogs.
    Molleda JM; Tardón RH; Gallardo JM; Martín-Suárez EM
    Vet J; 2008 Jun; 176(3):326-32. PubMed ID: 17466546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema.
    Androudi S; Letko E; Meniconi M; Papadaki T; Ahmed M; Foster CS
    Ocul Immunol Inflamm; 2005; 13(2-3):205-12. PubMed ID: 16019680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of intravitreal ranibizumab on corneal endothelium in age-related macular degeneration.
    Pérez-Rico C; Benítez-Herreros J; Castro-Rebollo M; Gómez-Sangil Y; Germain F; Montes-Mollón MA; Teus MA
    Cornea; 2010 Aug; 29(8):849-52. PubMed ID: 20508510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.
    Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B; Sauder G
    Ophthalmology; 2006 May; 113(5):800-4. PubMed ID: 16530840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of repeated injection of intravitreal triamcinolone on macular oedema in central retinal vein occlusion.
    Wang L; Song H
    Acta Ophthalmol; 2009 May; 87(3):285-9. PubMed ID: 18507724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of selective laser trabeculoplasty on intraocular pressure in patients with intravitreal steroid-induced elevated intraocular pressure.
    Rubin B; Taglienti A; Rothman RF; Marcus CH; Serle JB
    J Glaucoma; 2008; 17(4):287-92. PubMed ID: 18552614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of bromfenac ophthalmic solution on ocular inflammation following cataract surgery.
    Miyanaga M; Miyai T; Nejima R; Maruyama Y; Miyata K; Kato S
    Acta Ophthalmol; 2009 May; 87(3):300-5. PubMed ID: 19183412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complications of intravitreal steroid injections.
    Reichle ML
    Optometry; 2005 Aug; 76(8):450-60. PubMed ID: 16150412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Follow-up after intravitreal triamcinolone acetonide for exudative age-related macular degeneration.
    Jonas JB; Spandau UH; Kamppeter BA; Harder B
    Eye (Lond); 2007 Mar; 21(3):387-94. PubMed ID: 16410809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravitreal and orbital floor triamcinolone acetonide injections in noninfectious uveitis: a comparative study.
    Roesel M; Gutfleisch M; Heinz C; Heimes B; Zurek-Imhoff B; Heiligenhaus A
    Ophthalmic Res; 2009; 42(2):81-6. PubMed ID: 19478546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevation of intraocular pressure after intravitreal injection of triamcinolone acetonide in Taiwanese patients.
    Chang YC; Wu WC
    Kaohsiung J Med Sci; 2008 Feb; 24(2):72-7. PubMed ID: 18281223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion.
    Chen SD; Sundaram V; Lochhead J; Patel CK
    Am J Ophthalmol; 2006 May; 141(5):876-883. PubMed ID: 16527226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitic cataract.
    Dada T; Dhawan M; Garg S; Nair S; Mandal S
    J Cataract Refract Surg; 2007 Sep; 33(9):1613-8. PubMed ID: 17720079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency and management of raised intraocular pressure following intravitreal triamcinolone acetonide.
    Mahar PS; Memon AS
    J Coll Physicians Surg Pak; 2012 Nov; 22(11):699-702. PubMed ID: 23146849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequency and risk factors for intraocular pressure elevation after posterior sub-Tenon capsule triamcinolone acetonide injection.
    Iwao K; Inatani M; Kawaji T; Koga T; Mawatari Y; Tanihara H
    J Glaucoma; 2007 Mar; 16(2):251-6. PubMed ID: 17473740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cataract formation and other complications of intravitreal triamcinolone for macular edema.
    Thompson JT
    Am J Ophthalmol; 2006 Apr; 141(4):629-37. PubMed ID: 16564796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraocular pressure after intravitreal injection of triamcinolone acetonide.
    Jonas JB; Kreissig I; Degenring R
    Br J Ophthalmol; 2003 Jan; 87(1):24-7. PubMed ID: 12488256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.